Elucidating immune mechanisms causing hypertension during pregnancy

Physiology

Volumn 28, Issue 4, 2013, Pages 225-233

  LaMarca, Babbette ^a   Cornelius, Denise ^a   Wallace, Kedra ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANOXIA; DISEASE MODEL; FEMALE; HUMAN; HYPERTENSION; IMMUNE SYSTEM; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; RAT; REVIEW; UTERUS; VASCULARIZATION;

ANIMALS; ANOXIA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERTENSION; IMMUNE SYSTEM; PERFUSION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RATS; UTERUS;

EID: 84879652001     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00006.2013     Document Type: Review

References (59)

1. Abbus A, Lichtman A. Cellular and Molecular Immunology. General Properties of the Immune Response, Cells and Tissues of the Immune System. Philadelphia, PA: Elsevier, 2005, p. 163-188.
2. Abbus A, Lichtman A. Cellular and Molecular Immunology. General Properties of the Immune Response, Cells and Tissues of the Immune System. Philadelphia, PA: Elsevier, 2005, p. 189-215.
3. Abbus A, Lichtman A. Cellular and Molecular Immunology. General Properties of the Immune Response, Cells and Tissues of the Immune System. Philadelphia, PA: Elsevier, 2005, p. 243-274.
4. Cianchini G, Corona R, Frezzolini A, Ruffelli M, Didona B, Puddu P. Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature. Arch Dermatol 143: 1033-1038, 2007.
5. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 93: 17-25, 1994.
6. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37: 240-249, 1997.
7. Dechend R, Gratze P, Wallukat G, Shagdarsuren E, Plehm R, Brasen JH, Fiebeler A, Schneider W, Caluwaerts S, Vercruysse L, Pijnenborg R, Luft FC, Muller DN. Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 45: 742-746, 2005.
8. Dhillion P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, Mosely J, Martin JN Jr, Dechend R, LaMarca B. IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol 303: R353-R358, 2012.
9. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA. Shortand long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 44: 708-714, 2004.
10. Fukui A, Yokota M, Funamizu A, Nakamu R, Fukuhara R, Yamada K, Kimura H, Fukuyama A, Kamoi M, Tanaka K, Mizunuma H. Changes of NK cells in preeclampsia. Am J Reprod Immunol 67: 278-286, 2012.
11. Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48: 711-716, 2006.
12. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PCA. Study of angiotensin I. I. pressor response throughout primigravid pregnancy. J Clin Invest 52: 2682-2689, 1973.
13. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia: Linking placental ischemia with endothelial dysfunction. Hypertension 38: 718-722, 2001.
14. Granger JP, Alexander BT, Bennett WA, Khalil RA. Pathophysiology of pregnancy-induced hypertension. Microcirculation 9: 147-160, 2002.
15. Herse F, Dechend R, Harsem NK, Wallukat G, Janke J, Qadri F, Hering L, Muller DN, Luft FC, Staff AC. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49: 604-611, 2007.
16. Herse F, Lamarca B. Angiotensin II type 1 receptor autoantibody (at1-aa)-mediated pregnancy hypertension. Am J Reprod Immunol 69: 413-418, 2013.
17. Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, Markovic N, Thadhani R, Luft FC, Dechend R. Agonistic angiotensin ii type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 49: 612-617, 2007.
18. Irani RA, Zhang Y, Zhou CC, Blackwell SC, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Autoantibodymediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling. Hypertension 55: 1246-1253, 2010.
19. Jensen F, Wallukat G, Herse F, Budner O, El-Mousleh T, Costa SD, Dechend R, Zenclussen AC. CD19 CD5 cells as indicators of preeclampsia. Hypertension 59: 861-868, 2012.
20. Keiser SD, Veillon EW, Parrish MR, Bennett W, Cockrell K, Fournier L, Granger JP, Martin JN Jr, LaMarca BB. Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens 22: 1120-1125, 2009.
21. LaMarca B, Alexander B, Gilbert J, Ryan M, Sedeek M, Granger J. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gender Medicine 5: S133-S138, 2008.
22. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46: 1022-1025, 2005.
23. LaMarca BB, Cockrell K, Sullivan E, Bennett W, Granger JP. Role of Endothelin in Mediating Tumor Necrosis Factor-Induced Hypertension in Pregnant Rats. Hypertension 46: 82-86, 2005.
24. LaMarca BB, Parrish M, Ray LF, Murphy SR, Roberts L, Wallukat PGG, Wenzel K, Cockrell K, Martin Jr JN, Ryan MJ, Dechend R. Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. Hypertension 54: 905-909, 2009.
25. LaMarca B, Parrish MR, Wallace K. Agonistic autoantibodies to the angiotensin ii type i receptor cause pathophysiologic characteristics of preeclampsia. Gend Med 9: 139-146, 2012.
26. LaMarca BB, Speed J, Ray LF, Cockrell K, Wallukat G, Dechend R, Granger J. Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation of interferon, cytokine, and mediator. Inter J Res 3: 65-70, 2011.
27. LaMarca B, Wallace K, Herse F, Wallukat G, Weimer A, Dechend R. Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension 57: 865-871, 2011.
28. LaMarca BB, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Elevated agonistic autoantibodies to the angiotensin type 1 (AT1-AA) receptor in response to placental ischemia and TNF alpha in pregnant rats. Hypertension 52: 7-11, 2008.
29. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355: 992-1005, 2006.
30. Liao AH, Liu LP, Ding WP, Zhang L. Functional changes of human peripheral B lymphocytes in preeclampsia. Am J Reprod Immunol 61: 313-321, 2009.
31. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003.
32. Murphy SR, LaMarca BB, Cockrell K, Granger JP. Soluble fms-like tyrosine-1 induced hypertension: role of endothelin. Hypertension 55: 394-398, 2010.
33. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of anti-angiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-2869, 2011.
34. Novotny SR, Wallace K, Heath J, Moseley J, Dhillon P, Weimer A, Wallukat G, Herse F, Wenzel K, Martin JN Jr, Dechend R, LaMarca B. Activating autoantibodies to the angiotensin receptor are important in mediating hypertension in response to adoptive transfer of RUPP CD4 T Lymphocytes. Am J Physiol Regul Integr Comp Physiol 302: R1197-R1201, 2012.
35. Marc R, Parrish M, Ryan MJ, Glover P, Brewer J, Ray L, Dechend R, JMartin Jr JN, LaMarca BB. Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction. Gen Med 8: 184-188, 2011.
36. Prins J, Boelens H, Heimweg J, Van der Heide S, Dubois A, Van Oosterhout A, Erwich J. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertension Pregnancy 28: 300-311, 2009.
37. Redman CW, Sargent IL. Immunology of preeclampsia. Am J Reprod Immunol 63: 534-543, 2010.
38. Roberts JM, Gammill H. Insulin resistance in preeclampsia. Hypertension 47: 341-342, 2006.
39. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 46: 1243-1249, 2005.
40. Roberts L, LaMarca D, Fournier L, Bain J, Cockrell K, Granger JP. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 47: 615-618, 2006.
41. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 41: 437-445, 2003.
42. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 161: 1200-1204, 1989.
43. Roberts JM, Von Versen-Hoeynck F. Maternal fetal/placental interactions and abnormal pregnancy outcomes. Hypertension 49: 15-16, 2007.
44. Santner-Nanan B, Peek M, Khanam R, Richarts L, Zhu E, Fazekas de St G, Nanan R. Systemic increase in the ration between FoxP3 and IL-17 producing CD4 T cells in healthy pregnancy but not in preeclampsia. J Immunol 183: 7023-7030, 2009.
45. Sargent I, Borzychowski A, Redman C. Immunoregulation in normal pregnancy and preeclampsia: an overview. Reprod Biomed Online 13: 680-686, 2006.
46. Stepan H, Faber R, Wessel N, Wallukat G, Schultheiss HP, Walther T. Relation between circulating angiotensin ii type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab 91: 2424-2427, 2006.
47. Stepan H, Walther T. Questionable role of the angiotensin ii receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension 50: e3, 2007.
48. Taylor RN, de Groot CJ, Cho YK, Lim KH. Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia. Semin Reprod Endocrinol 16: 17-31, 1998.
49. Thadhani RI, Johnson RJ, Karumanchi SA. Hypertension during pregnancy: a disorder begging for pathophysiological support. Hypertension 46: 1250-1251, 2005.
50. Vacca P, Mingari MC, Moretta L. Natural killer cells in human pregnancy. J Rep Imm 97: 14-19, 2013.
51. Wallace K, Novotny S, Weimer A, Martin JN, LaMarca B. CD4 T helper cells stimulated in response to placental ischemia mediate hypertension in pregnant rats. Hypertension 57: 949-955, 2011.
52. Wallace K, Novotny S, Heath J, Moseley J, Martin JN Jr, Owens MY, LaMarca B. Hypertension in response to CD4 T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. Am J Physiol Regul Integr Comp Physiol 303: R144-R149, 2012.
53. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103: 945-952, 1999.
54. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss HP, Faber R, Stepan H. Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 46: 1275-1279, 2005.
55. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 32: 157-169, 1996.
56. Wenzel K, Rajakumar A, Haase H, Geusens N, Hubner N, Schulz H, Brewer J, Roberts L, Hubel CA, Herse F, Hering L, Qadri F, Lindschau C, Wallukat G, Pijnenborg R, Heidecke H, Riemekasten G, Luft FC, Muller DN, Lamarca B, Dechend R. Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats. Hypertension 58: 77-84, 2011.
57. Wu CF, Huang FD, Sui RF, Sun JX. Preeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cells. Reprod Biol Endocrinol 10: 28, 2012.
58. Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50: 269-275, 2007.
59. Zhou CC, Irani RA, Dai Y, Blackwell SC, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Autoantibody-mediated IL6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol 186: 6024-6034, 2011.